CN102512455A - 一种治疗痔疮漏疮的中药制剂 - Google Patents
一种治疗痔疮漏疮的中药制剂 Download PDFInfo
- Publication number
- CN102512455A CN102512455A CN2011104365171A CN201110436517A CN102512455A CN 102512455 A CN102512455 A CN 102512455A CN 2011104365171 A CN2011104365171 A CN 2011104365171A CN 201110436517 A CN201110436517 A CN 201110436517A CN 102512455 A CN102512455 A CN 102512455A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- anal fistula
- vaseline
- scorpio
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 208000002287 Hemorrhoids Diseases 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 title claims abstract description 16
- 206010002156 Anal fistula Diseases 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 13
- 229940099259 Vaseline Drugs 0.000 claims abstract description 10
- 238000005516 engineering process Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 5
- 241000255791 Bombyx Species 0.000 claims description 11
- 241000522620 Scorpio Species 0.000 claims description 11
- 239000009490 scorpio Substances 0.000 claims description 11
- 239000000470 constituent Substances 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 238000011084 recovery Methods 0.000 abstract description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nMzAwcHgnIGhlaWdodD0nMzAwcHgnIHZpZXdCb3g9JzAgMCAzMDAgMzAwJz4KPCEtLSBFTkQgT0YgSEVBREVSIC0tPgo8cmVjdCBzdHlsZT0nb3BhY2l0eToxLjA7ZmlsbDojRkZGRkZGO3N0cm9rZTpub25lJyB3aWR0aD0nMzAwLjAnIGhlaWdodD0nMzAwLjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8cGF0aCBjbGFzcz0nYm9uZC0wIGF0b20tMCBhdG9tLTEnIGQ9J00gNTIuNSwyMDYuMCBMIDExNS4zLDI0NS4xJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoyLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0xMCBhdG9tLTcgYXRvbS0wJyBkPSdNIDcwLjIsMTM0LjEgTCA1Mi41LDIwNi4wJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoyLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0xIGF0b20tMSBhdG9tLTInIGQ9J00gMTE1LjMsMjQ1LjEgTCAxNzIuMCwxOTcuNCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6Mi4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtMiBhdG9tLTIgYXRvbS0zJyBkPSdNIDE3Mi4wLDE5Ny40IEwgMjQyLjgsMjE5LjUgTCAyNDQuOSwyMTAuOCBaJyBzdHlsZT0nZmlsbDojM0I0MTQzO2ZpbGwtcnVsZTpldmVub2RkO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoyLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxOycgLz4KPHBhdGggY2xhc3M9J2JvbmQtMyBhdG9tLTIgYXRvbS00JyBkPSdNIDE3Mi4wLDE5Ny40IEwgMTg5LjcsMTI1LjUnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiMzQjQxNDM7c3Ryb2tlLXdpZHRoOjIuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+CjxwYXRoIGNsYXNzPSdib25kLTExIGF0b20tOCBhdG9tLTInIGQ9J00gMTQ0LjEsMTI4LjggTCAxNzIuMCwxOTcuNCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6Mi4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNCBhdG9tLTQgYXRvbS01JyBkPSdNIDE5Ny40LDEyMy4yIEwgMTk2LjgsMTIxLjgnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiMzQjQxNDM7c3Ryb2tlLXdpZHRoOjEuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+CjxwYXRoIGNsYXNzPSdib25kLTQgYXRvbS00IGF0b20tNScgZD0nTSAyMDUuMCwxMjAuOSBMIDIwMy45LDExOC4xJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC00IGF0b20tNCBhdG9tLTUnIGQ9J00gMjEyLjYsMTE4LjYgTCAyMTEuMCwxMTQuNScgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNCBhdG9tLTQgYXRvbS01JyBkPSdNIDIyMC4zLDExNi4zIEwgMjE4LjAsMTEwLjgnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiNFODQyMzU7c3Ryb2tlLXdpZHRoOjEuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+CjxwYXRoIGNsYXNzPSdib25kLTQgYXRvbS00IGF0b20tNScgZD0nTSAyMjcuOSwxMTQuMCBMIDIyNS4xLDEwNy4xJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojRTg0MjM1O3N0cm9rZS13aWR0aDoxLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC00IGF0b20tNCBhdG9tLTUnIGQ9J00gMjM1LjUsMTExLjcgTCAyMzIuMiwxMDMuNCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6I0U4NDIzNTtzdHJva2Utd2lkdGg6MS4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNSBhdG9tLTQgYXRvbS02JyBkPSdNIDE4OS43LDEyNS41IEwgMTI2LjksODYuNCcgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6Mi4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtNiBhdG9tLTYgYXRvbS03JyBkPSdNIDEyNi45LDg2LjQgTCA3MC4yLDEzNC4xJyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoyLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC03IGF0b20tNyBhdG9tLTgnIGQ9J00gNzAuMiwxMzQuMSBMIDE0NC4xLDEyOC44JyBzdHlsZT0nZmlsbDpub25lO2ZpbGwtcnVsZTpldmVub2RkO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoyLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxJyAvPgo8cGF0aCBjbGFzcz0nYm9uZC0xMiBhdG9tLTcgYXRvbS0xMScgZD0nTSA3MC4yLDEzNC4xIEwgNDYuMiw5OC43IEwgMzkuNCwxMDQuNCBaJyBzdHlsZT0nZmlsbDojM0I0MTQzO2ZpbGwtcnVsZTpldmVub2RkO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTojM0I0MTQzO3N0cm9rZS13aWR0aDoyLjBweDtzdHJva2UtbGluZWNhcDpidXR0O3N0cm9rZS1saW5lam9pbjptaXRlcjtzdHJva2Utb3BhY2l0eToxOycgLz4KPHBhdGggY2xhc3M9J2JvbmQtOCBhdG9tLTggYXRvbS05JyBkPSdNIDE0NC4xLDEyOC44IEwgMTQ5LjEsNTQuOScgc3R5bGU9J2ZpbGw6bm9uZTtmaWxsLXJ1bGU6ZXZlbm9kZDtzdHJva2U6IzNCNDE0MztzdHJva2Utd2lkdGg6Mi4wcHg7c3Ryb2tlLWxpbmVjYXA6YnV0dDtzdHJva2UtbGluZWpvaW46bWl0ZXI7c3Ryb2tlLW9wYWNpdHk6MScgLz4KPHBhdGggY2xhc3M9J2JvbmQtOSBhdG9tLTggYXRvbS0xMCcgZD0nTSAxNDQuMSwxMjguOCBMIDIwOC4xLDkxLjYnIHN0eWxlPSdmaWxsOm5vbmU7ZmlsbC1ydWxlOmV2ZW5vZGQ7c3Ryb2tlOiMzQjQxNDM7c3Ryb2tlLXdpZHRoOjIuMHB4O3N0cm9rZS1saW5lY2FwOmJ1dHQ7c3Ryb2tlLWxpbmVqb2luOm1pdGVyO3N0cm9rZS1vcGFjaXR5OjEnIC8+Cjx0ZXh0IHg9JzI0OS40JyB5PScxMTIuNCcgY2xhc3M9J2F0b20tNScgc3R5bGU9J2ZvbnQtc2l6ZToyOXB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPk88L3RleHQ+Cjx0ZXh0IHg9JzI2OS45JyB5PScxMTIuNCcgY2xhc3M9J2F0b20tNScgc3R5bGU9J2ZvbnQtc2l6ZToyOXB4O2ZvbnQtc3R5bGU6bm9ybWFsO2ZvbnQtd2VpZ2h0Om5vcm1hbDtmaWxsLW9wYWNpdHk6MTtzdHJva2U6bm9uZTtmb250LWZhbWlseTpzYW5zLXNlcmlmO3RleHQtYW5jaG9yOnN0YXJ0O2ZpbGw6I0U4NDIzNScgPkg8L3RleHQ+Cjx0ZXh0IHg9JzEzLjYnIHk9JzkyLjMnIGNsYXNzPSdhdG9tLTExJyBzdHlsZT0nZm9udC1zaXplOjI5cHg7Zm9udC1zdHlsZTpub3JtYWw7Zm9udC13ZWlnaHQ6bm9ybWFsO2ZpbGwtb3BhY2l0eToxO3N0cm9rZTpub25lO2ZvbnQtZmFtaWx5OnNhbnMtc2VyaWY7dGV4dC1hbmNob3I6c3RhcnQ7ZmlsbDojM0I0MTQzJyA+SDwvdGV4dD4KPC9zdmc+Cg== data:image/svg+xml;base64,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 C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 abstract 3
- 241000255789 Bombyx mori Species 0.000 abstract 3
- 229940116229 Borneol Drugs 0.000 abstract 3
- 241000239226 Scorpiones Species 0.000 abstract 3
- 241000282898 Sus scrofa Species 0.000 abstract 3
- 229930006709 borneol Natural products 0.000 abstract 3
- 238000001816 cooling Methods 0.000 abstract 2
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 231100000486 side effect Toxicity 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 201000010099 disease Diseases 0.000 description 5
- 238000001050 pharmacotherapy Methods 0.000 description 3
- 210000004369 Blood Anatomy 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 208000000264 Deglutition Disorders Diseases 0.000 description 1
- 208000001848 Dysentery Diseases 0.000 description 1
- 206010013950 Dysphagia Diseases 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000000315 cryotherapy Methods 0.000 description 1
- 230000003203 everyday Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 101700010564 penG Proteins 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000001568 sexual Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000001256 tonic Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Abstract
本发明公开一种治疗痔疮漏疮的中药制剂，其组成成分为：僵蚕1～3g、全虫0.5～1.5g、猪胆粉1～2g、冰片0.005～0.015g、清凉油1～2g、凡士林2～5g，其制作工艺为：首先将僵蚕、全虫、猪胆粉、冰片粉碎成能够通过270目筛网细粉，然后按上述比例量取僵蚕、全虫、猪胆粉、冰片细粉，最后按比例加入清凉油和凡士林，调匀装袋即可。本发明治疗痔疮漏疮使用方便，无毒副作用，经500例患者临床，治愈率100％。
Description
一种治疗痔疮漏疮的中药制剂
技术领域
[0001] 本发明涉及一种中药制剂，尤其是一种治疗痔疮漏疮的中药制剂。 背景技术
[0002] 谷道生疽曰脏毒.最痛.初则内疏.次则内托.排脓溃后.慎房事.戒浓味气怒 .若不谨守.恐生漏毒.亦有丧生者.黑者难治。由此可知，在过去痔疮漏疮也是一种疑难病症。目前，治疗痔疮漏疮的方法很多，有药物疗法、手术疗法，药物疗法包括口服中药、 外用药物和药物注射疗法；手术疗法即为手术切除痔核；另外还有其他疗法，例如红外线治疗、冷冻疗法和激光疗法。手术疗法不但给患者带来痛苦，而且复发率很高；其他疗法给患者带来的痛苦虽说较手术疗法轻，但复发率较手术疗法更高；就药物疗法来说，目前好没有发现能够达到治疗后不复发的药物。因此，研究一种能够治愈痔疮漏疮并且不复发的中药制剂，是目前需要解决的技术问题。
发明内容
[0003] 本发明所要解决的技术问题是提供一种能够治愈痔疮漏疮并且不复发的中药制剂。
[0004] 本发明解决其技术问题的技术方案是：
一种治疗痔疮漏疮的中药制剂，其组成成分为：僵蚕1〜3g、全虫0. 5〜1. 5g、猪胆粉 1〜2g、冰片0. 005〜0. 015g、清凉油1〜2g、凡士林2〜5g，其制作工艺为：首先将僵蚕、 全虫、猪胆粉、冰片粉碎成能够通过270目筛网细粉，然后按上述比例量取僵蚕、全虫、猪胆粉、冰片细粉，最后按比例加入清凉油和凡士林，调勻装袋即可。
[0005] 本发明解决其技术问题的优选技术方案是：
其组成成分为：僵蚕2g、全虫lg、猪胆粉1. 5g、冰片0. Olg、清凉油1. 5g、凡士林3. 3g。
[0006] 治疗方法：
先将患处洗净，用本发明制剂擦涂患处，每日早晚各一次。
[0007] 与现有技术相比，本发明使用方便，无毒副作用，经500例患者临床，治愈率 100%。
[0008] 下面通过几个典型病例具体说明本发明的的治疗效果：
病例一，岳某某，男，43岁，河北曲周县城关镇北街人，患痔疮。采用本药治疗，10 日痊愈，愈后多年吃辣椒、喝酒从没复发过。
[0009] 病例二，网某某，女，53岁，河北永年县张西堡人，患痔疮连漏疮，采用本发明制剂治疗，15日痊愈。愈后多年吃辣椒，从没复发过。
[0010] 病例三，高某某，男，34岁，河北大名县束管镇人，司机，患痔疮，采用本发明制剂治疗，15日痊愈，多年未复发。
[0011] 病例四，李某某，女，37岁，邯郸市丛台区，白领人士，患痔疮，采用本发明制剂治疗，10日痊愈。[0012] 病例五，彭某某，女，44岁，邯郸市邯山区人，患漏疮，采用本发明制剂治疗，12日痊愈。
具体实施方式
[0013] 下面通过列表的方式列举本发明的10个具体实施例，全部成分均为市场直接购
得，其制作工艺为：首先将僵蚕、全虫、猪胆粉、冰片粉碎成能够通过270目筛网细粉，然后
按上述比例量取僵蚕、全虫、猪胆粉、冰片细粉，最后按比例加入清凉油和凡士林，调勻装袋即可。
[0014] 单位：g
Claims (2)
1. 一种治疗痔疮漏疮的中药制剂，其特征在于：其组成成分为：僵蚕1〜3g、全虫 0. 5〜1. 5g、猪胆粉1〜2g、冰片0. 005〜0. 015g、清凉油1〜2g、凡士林2〜5g，其制作工艺为：首先将僵蚕、全虫、猪胆粉、冰片粉碎成能够通过270目筛网细粉，然后按上述比例量取僵蚕、全虫、猪胆粉、冰片细粉，最后按比例加入清凉油和凡士林，调勻装袋即可。
2.根据权利要求1所述的一种治疗痔疮漏疮的中药制剂，其特征在于：其组成成分为： 僵蚕2g、全虫lg、猪胆粉1. 5g、冰片0. Olg、清凉油1. 5g、凡士林3. 3g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104365171A CN102512455B (zh) | 2011-12-23 | 2011-12-23 | 一种治疗痔疮漏疮的中药制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104365171A CN102512455B (zh) | 2011-12-23 | 2011-12-23 | 一种治疗痔疮漏疮的中药制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512455A true CN102512455A (zh) | 2012-06-27 |
| CN102512455B CN102512455B (zh) | 2013-04-17 |
Family
ID=46283709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104365171A Expired - Fee Related CN102512455B (zh) | 2011-12-23 | 2011-12-23 | 一种治疗痔疮漏疮的中药制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512455B (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163764A (zh) * | 1996-04-26 | 1997-11-05 | 李相前 | 一种治疗痔、瘘的中药制剂 |
| JP2003055193A (ja) * | 2001-08-07 | 2003-02-26 | Taisho Pharmaceut Co Ltd | 清涼化剤含有ゲル状外用剤 |
| CN1726941A (zh) * | 2005-04-28 | 2006-02-01 | 俞存华 | 治疗顽固性痔疮的内服药 |
| CN1879709A (zh) * | 2006-05-08 | 2006-12-20 | 郭关林 | 一种治疗痔疮和肛瘘疾病的中药 |
| CN101912473A (zh) * | 2010-08-12 | 2010-12-15 | 张云德 | 一种根治痔疮的组合药物 |
-
2011
- 2011-12-23 CN CN2011104365171A patent/CN102512455B/zh not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163764A (zh) * | 1996-04-26 | 1997-11-05 | 李相前 | 一种治疗痔、瘘的中药制剂 |
| JP2003055193A (ja) * | 2001-08-07 | 2003-02-26 | Taisho Pharmaceut Co Ltd | 清涼化剤含有ゲル状外用剤 |
| CN1726941A (zh) * | 2005-04-28 | 2006-02-01 | 俞存华 | 治疗顽固性痔疮的内服药 |
| CN1879709A (zh) * | 2006-05-08 | 2006-12-20 | 郭关林 | 一种治疗痔疮和肛瘘疾病的中药 |
| CN101912473A (zh) * | 2010-08-12 | 2010-12-15 | 张云德 | 一种根治痔疮的组合药物 |
Non-Patent Citations (1)
| Title |
|---|
| 史书达: "《中国家庭自疗神效千方经典》", 31 December 2010, 内蒙古科学技术出版社 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512455B (zh) | 2013-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103285122A (zh) | 一种治疗猪疥癣病的中药组合物及其制备方法 | |
| CN103110850A (zh) | 一种治疗痔疮的膏剂 | |
| CN102512455B (zh) | 一种治疗痔疮漏疮的中药制剂 | |
| CN103751480B (zh) | 一种治疗习惯性流产中药 | |
| CN103690583B (zh) | 一种药酒及其制备方法和应用 | |
| CN101474381A (zh) | 治疗急慢性鼻炎的药物及其制备方法和鼻腔送药器 | |
| CN104524247A (zh) | 一种治疗偏头痛的药物组合物及其用途 | |
| CN104523872A (zh) | 治疗风湿性关节炎的中药组合物及制法 | |
| CN102988566B (zh) | 一种治疗软组织挫伤的中药组合物及其制备方法 | |
| CN103599274A (zh) | 一种治疗过敏性鼻炎的中药 | |
| CN101234150B (zh) | 一种发泡祛毒、通经散结的药物组合物及其制备方法 | |
| CN102335322A (zh) | 一种治疗白癜风的药物配方 | |
| CN102949467A (zh) | 一种治疗湿热瘀阻所致慢性盆腔炎的药物组合物 | |
| CN104666516A (zh) | 一种消炎止带外洗液 | |
| CN103599213A (zh) | 一种治疗骨折的药物组合物及其制备方法 | |
| CN102512474B (zh) | 一种治疗鼻息肉的药膏 | |
| CN105327019A (zh) | 一种治疗口腔溃疡的降雪丹中药制剂 | |
| CN2768815Y (zh) | 中药护脐止痛止泻袋 | |
| CN103463324B (zh) | 一种预防或治疗口腔溃疡的药物组合物及应用 | |
| CN101417021B (zh) | 一种戒毒外用中药及其制备方法 | |
| CN103704889B (zh) | 一种疮瘘术后快速愈合的中药内裤 | |
| CN103705874A (zh) | 一种治疗锁骨上及锁骨下（腋下）及腹股沟淋巴结肿大的外用中药 | |
| CN103599280B (zh) | 一种外敷预防泌尿系结石再复发的中药组合物 | |
| CN102872269B (zh) | 一种治疗小儿急性扁桃体炎的中药组合物 | |
| CN103393884B (zh) | 一种治疗痤疮的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| C06 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| GR01 | Patent grant | ||
| C14 | Grant of patent or utility model | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130417 Termination date: 20131223 |
|
| C17 | Cessation of patent right |